Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Inflammation × Folic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 10 Carcinoma, Non-Small-Cell Lung 7 Colorectal Neoplasms 6 Recurrence 5 Neoplasm Metastasis 4 Colonic Neoplasms 4 Rectal Neoplasms 3 Lymphoma, T-Cell, Peripheral 3 Sezary Syndrome 2 Ovarian Neoplasms 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, T-Cell 2 Lung Neoplasms 2 Infertility 2 Hyperandrogenism 2 Head and Neck Neoplasms 2 Atypical Squamous Cells of the Cervix 2 Anovulation 2 Adenoma 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Thyroid Diseases 1 Squamous Intraepithelial Lesions 1 Smoking 1 Psoriasis 1 Precancerous Conditions 1 Polyps 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

Exercise 3 Vitamin D 2 Tea 2 Sufentanil 2 Spironolactone 2 Oxycodone 2 Omeprazole 2 Metformin 2 Colchicine 2 ziprasidone 1 soybean oil, phospholipid emulsion 1 salicylsalicylic acid 1 ginger extract 1 falcarinol 1 falcarindiol 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Sulindac 1 Sodium Salicylate 1 Sevoflurane 1 Sevelamer 1 Rocuronium 1 Riluzole 1 Resistance Training 1 Radiotherapy, Conformal 1 Propofol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02302326 2020-02-26

PI12/1984

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Phase NA Completed

Inflammation, Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡